LAM
ANGO icon

Lapides Asset Management’s AngioDynamics ANGO Stock Holding History

Lapides Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$4.49M Buy
430,600
+132,400
+44% +$1.27M 2.94% 12
2023
Q1 		$3.08M Buy
298,200
+84,700
+40% +$1.08M 1.87% 26
2022
Q4 		$2.94M Buy
213,500
+102,100
+92% +$1.42M 1.57% 29
2022
Q3 		$2.28M Hold
111,400
– – 1.3% 33
2022
Q2 		$2.16M Hold
111,400
– – 1.08% 36
2022
Q1 		$2.4M Sell
111,400
-28,300
-20% -$642K 1.05% 37
2021
Q4 		$3.85M Sell
139,700
-37,500
-21% -$1.03M 1.68% 24
2021
Q3 		$4.6M Sell
177,200
-21,000
-11% -$562K 1.9% 20
2021
Q2 		$5.38M Sell
198,200
-108,900
-35% -$2.66M 2.14% 19
2021
Q1 		$7.19M Sell
307,100
-139,400
-31% -$2.82M 3.01% 8
2020
Q4 		$6.84M Sell
446,500
-3,600
-0.8% -$45.7K 2.94% 8
2020
Q3 		$5.43M Buy
450,100
+222,000
+97% +$2.11M 2.98% 9
2020
Q2 		$2.32M Buy
228,100
+101,000
+79% +$1.04M 1.34% 29
2020
Q1 		$1.33M Buy
+127,100
New +$1.6M 1% 35
2019
Q4 		– Sell
-22,500
Closed -$414K – 66
2019
Q3 		$414K Hold
22,500
– – 0.21% 60
2019
Q2 		$443K Sell
22,500
-2,600
-10% -$52.9K 0.2% 67
2019
Q1 		$574K Sell
25,100
-36,000
-59% -$782K 0.22% 66
2018
Q4 		$1.23M Sell
61,100
-168,500
-73% -$3.49M 0.5% 50
2018
Q3 		$4.99M Sell
229,600
-72,400
-24% -$1.61M 1.09% 36
2018
Q2 		$6.72M Sell
302,000
-125,100
-29% -$2.56M 1.43% 27
2018
Q1 		$7.37M Sell
427,100
-12,800
-3% -$214K 1.62% 22
2017
Q4 		$7.32M Sell
439,900
-33,400
-7% -$570K 1.59% 21
2017
Q3 		$8.09M Sell
473,300
-13,600
-3% -$228K 1.66% 20
2017
Q2 		$7.89M Hold
486,900
– – 1.53% 22
2017
Q1 		$8.45M Sell
486,900
-25,000
-5% -$418K 1.58% 23
2016
Q4 		$8.64M Sell
511,900
-62,500
-11% -$1.04M 1.55% 21
2016
Q3 		$10.1M Sell
574,400
-63,600
-10% -$1.03M 1.72% 20
2016
Q2 		$9.17M Buy
638,000
+700
+0.1% +$8.75K 1.69% 19
2016
Q1 		$7.83M Sell
637,300
-63,200
-9% -$698K 1.4% 30
2015
Q4 		$8.5M Buy
700,500
+8,400
+1% +$103K 1.49% 25
2015
Q3 		$9.13M Sell
692,100
-7,200
-1% -$109K 1.57% 22
2015
Q2 		$11.5M Buy
699,300
+121,300
+21% +$2.01M 1.82% 20
2015
Q1 		$10.3M Sell
578,000
-310,600
-35% -$5.77M 1.71% 21
2014
Q4 		$16.9M Sell
888,600
-10,900
-1% -$185K 2.28% 17
2014
Q3 		$12.3M Buy
899,500
+74,700
+9% +$1.07M 1.74% 24
2014
Q2 		$13.5M Buy
824,800
+14,500
+2% +$210K 1.82% 22
2014
Q1 		$12.8M Hold
810,300
– – 1.79% 22
2013
Q4 		$13.9M Hold
810,300
– – 1.9% 20
2013
Q3 		$10.7M Hold
810,300
– – 1.42% 25
2013
Q2 		$9.14M Buy
+810,300
New +$8.62M 1.3% 27

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lapides Asset Management's ANGO Position: Q2 2023 in Review

Lapides Asset Management increased its AngioDynamics (ANGO) stake by 44% in Q2 2023, buying an estimated $1.27M and bringing the position to 430,600 shares worth $4.49M. The position accounts for 2.94% of the portfolio, ranked #12.

Lapides Asset Management first reported a position in ANGO in Q2 2013 and has held it in 40 quarters since. The position peaked at $16.9M in Q4 2014. 156 funds tracked by Wall St. Rank hold ANGO as of Q2 2023.

  • Lapides Asset Management held 430,600 shares of AngioDynamics worth $4.49M as of Q2 2023.
  • Lapides Asset Management bought 132,400 AngioDynamics shares in Q2 2023, an estimated $1.27M.
  • AngioDynamics made up 2.94% of Lapides Asset Management's portfolio in Q2 2023, its #12 holding.
  • Lapides Asset Management first reported a position in AngioDynamics in Q2 2013 and has held it in 40 quarters since.
  • Lapides Asset Management's AngioDynamics position peaked at $16.9M in Q4 2014.
  • 156 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2023.

Based on Lapides Asset Management's 13F filing for Q2 2023, filed 4 Aug 2023.